Trial record 1 of 1 for:
Nous-209-01
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04041310 |
Recruitment Status :
Recruiting
First Posted : August 1, 2019
Last Update Posted : April 17, 2024
|
Sponsor:
Nouscom SRL
Collaborator:
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Nouscom SRL
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | March 15, 2025 |
Estimated Study Completion Date : | July 15, 2026 |